TITLE

John E. Lincoln

PUB. DATE
November 2009
SOURCE
Journal of Validation Technology;Autumn2009, Vol. 15 Issue 4, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article features John E. Lincoln, member of the Editorial Advisory Board of the "Journal of Validation Technology." Lincoln is principal of J. E. Lincoln and Associates which serves the industries regulated by the U.S. Food & Drug Administration (FDA). He specializes in medical device good manufacturing practices and standard operating procedures. He has worked in Abbott Laboratories, Mallinckrodt Medical, Hospira and Integra. He has also published articles on culture change, training and regulatory affairs.
ACCESSION #
47337016

 

Related Articles

  • FDA revamps advisory panel selection, voting procedures.  // Medical Device Daily;11/26/2007, Vol. 11 Issue 225, p2 

    The article reports on the decision by U.S. Food and Drug Administration (FDA) to change its advisory panel selection and voting procedures in order to boost the transparency of the functions of its advisory committees. Concerns regarding the voting process were raised. The FDA recommended...

  • PHAC to publicly disclose conflicts of interest of external advisors serving on advisory committees. Collier, Roger // CMAJ: Canadian Medical Association Journal;8/9/2011, Vol. 183 Issue 11, pE707 

    The article reports that Public Health Agency of Canada (PHAC) is ready to publicly disclose its financial ties to industry without requiring external experts serving on advisory committees. PHAC Media Relations Advisor Charlene Wiles mentions that the agency needs external experts to privately...

  • FDA forms risk management advisory panel.  // Medical Marketing & Media;Feb2002, Vol. 37 Issue 2, p30 

    Reports on the development of an advisory panel by the U.S. Food and Drug Administration. Expertise in risk perception and clinical pharmacology; Detection of medication errors.

  • FDA created drug safety/risk panel.  // Medical Marketing & Media;Mar2002, Vol. 37 Issue 3, p22 

    Reports on the formation of Drug Safety and Risk Management Subcommittee advisory panel by the U.S. Food and Drug Administration.

  • Affirmative inaction at the FDA.  // Nature Medicine;Nov2010, Vol. 16 Issue 11, p1173 

    The article focuses the analysis made by the Washington, D.C.-based healthcare policy group Prevision Policy on the allegations against the U.S. Food and Drug Administration (FDA) on whether or not it follows advice from advisory committees regarding the approval of a new medicine.

  • mdi Consultants, Inc.  // Medical Product Outsourcing;Dec2011 Outsourcing Directory, Vol. 9 Issue 10, p94 

    The article profiles MDI Consultants Inc. located in Great Neck, New York. It says that the medical device industry is provided by MDI with the U.S. Food and Drug Administration (FDA) regulatory and quality system consulting since 1978. It mentions the On-Demand training program of the company...

  • Product Briefs.  // Medical Device Daily;6/15/2011, Vol. 15 Issue 115, p9 

    This section offers medical device news briefs. A new physiologic simulated use test systems was introduced by BDC Laboratories that allows healthcare practitioners to study critical stent, stent graft and TAVI heart valve device delivery systems. The VeinViewer Vision OmniMount was released by...

  • Hackable Medical Devices--Is There a Solution?  // Medical Product Outsourcing;May2012, Vol. 10 Issue 4, p12 

    The article reports on the issuance of a letter by the Information Security and Privacy Advisory Board (ISPAB) to the U.S. Department of Health and Human Services and the Office of Management and Budget in 2012. The letter of ISBAP expressed concern over companies to report device security...

  • US consumer group attacks FDA.  // Pharmaceutical Technology Europe;Feb2007, Vol. 19 Issue 2, p12 

    The article reports on the results of a study published by Public Citizen which claim that the U.S. Food and Drug Administration (FDA) is not using its own advisory committees effectively in approving new drugs. They also discovered that FDA often allows drug companies to make an oral...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics